Mary Norine Walsh, MD
September 29th, 2014
The Implications of PARADIGM-HF for Clinical Practice
Clyde Yancy, MD and Mary Norine Walsh, MD
Clyde Yancy and Mary Norine Walsh offer their perspectives on the much-discussed PARADIGM-HF trial.
NEJM Journal Watch — Recent Cardiology Articles- Recovery from Metabolic Syndrome Reduces Cardiovascular Risk
- Percutaneous Treatment of Tricuspid Regurgitation?
- Assessing the Progression of Stage B Aortic Regurgitation: Are the Guidelines Right?
- Does Testosterone Therapy Confer Risk for Venous Thromboembolism?
- Does ARNI Therapy for Heart Failure with Reduced Ejection Fraction Improve Health Status?
-